DEC 01, 2014
Comprehensive Ophthalmology
The National Eye Institute has granted researchers at the Icahn School of Medicine at Mount Sinai a 5-year, $1 million grant to develop new stem cell therapies for ocular surface disease.
The grant will support research into viable stem cell sources, recreation of ocular stem cells from eyelid or oral skin cells, molecular pathways of ocular and orbital development and biomaterials to restore vision, according to the press release.
“Our findings will allow the creation of transplantable eye tissue that can restore the ocular surface,” Albert Y. Wu, MD, PhD, assistant professor in the department of ophthalmology at the Icahn School of Medicine at Mount Sinai, said in the press release.